30
CARDIOVASCULAR
hamburger
JETi

Percutaneous thrombectomy with the JETi™ Peripheral Thrombectomy System for the treatment of venous thrombosis

Overview: Retrospective Study

Cournoyer-Rodrigue et al., JVIR. 2019.

Background
Mechanical and pharmacomechanical based thrombectomy may improve clinical outcomes, reduce concomitant CDT and lessen need for intensive care unit stays compared to anticoagulation alone.

Objective
To evaluate the safety and efficacy of JETi™ Thrombectomy System in treating acute venous thrombosis.

Method
Retrospective evaluation of 18 consecutive patients with 21 instances of acute venous thrombosis in JETi™ Thrombectomy System new user facility.

Primary Endpoints
Technical Success Rate (restoration of antegrade flow with or without additional treatment of an underlying obstructive lesion) and Procedural Success Rate (technical success with or without the addition of overnight CDT).

Clinical Outcomes

The JETi™ Peripheral Thrombectomy System achieved a 100% procedural success rate in 18 consecutive patients with a wide variety of target treatment vessels and had ZERO reports of blood transfusions, hypotension or hemolysis..

  Procedural Success Rate Single-Session Clot Reduction Overall Clot Reduction
(Single-Session + Overnight CDT)
Iliofemoral Vein (n=9) 100% 81% 96%
Axillosubclavian Vein (n=10) 100% 100% 100%
Portal Vein (n=2) 100% 100% 100%

*5 patients required overnight CDT.

JETi™ system achieved a 100% procedural success rate in a wide variety of target treatment vessels at a brand-new JETi™ user facility.

100%

JETi™ system can achieve successful venous thrombectomy without overnight catheter directed thrombolysis in most patients.

Success

Reducing the need for overnight thrombolytics can lessen utilization of hospital resources and decrease intensive care unit stays resulting in lower costs compared with CDT.

Lower cost
Request a Demo

Reference:

Cournoyer-Rodrigue et al., JVIR. 2019.

MAT-2209359 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.